Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2024Molecular ImmunologyOpen Access

Humanization of a mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

LZLingjun ZhangKAKathryn L. ArmourJCJin Chen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e6fb8ab6db643587675bf2https://doi.org/10.1016/j.molimm.2024.03.010
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic Evaluation of a C3-Targeting Small Nucleic Acid Drug in a Spontaneous Humanized C3 Glomerulopathy Mouse Model 22568452026
  2. 2Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only2000 · 61 citations
  3. 3A genetically engineered mouse/human chimeric antibody targeting CD99 enhances antibody-dependent cellular phagocytosis against human mantle cell lymphoma Z138 cells2024
  4. 4The Humanization and Maturation of an Anti-PrPc Antibody2024 · 1 citations
  5. 5CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn2026